Literature DB >> 11193279

Transfusion requirements during continuous veno-venous haemofiltration: -the importance of filter life.

M W Cutts1, A N Thomas, R Kishen.   

Abstract

OBJECTIVE: To investigate the relationship between loss of haemofilter circuits due to blood clots and requirement for blood transfusion in intensive care patients.
DESIGN: Retrospective case note review.
SETTING: A British, nine-bed, tertiary, medical and surgical intensive care unit (ICU) serving a 950-bed university teaching hospital. PATIENTS: Thirty-three ICU patients requiring haemofiltration for more than 48 h. Thirty-three comparison patients requiring 7 or more days of intensive care, without haemofiltration.
METHODS: ICU, haemofiltration and haematology records were examined retrospectively. Note was taken of demographic data, daily haemoglobin concentrations and the dates and numbers of blood transfusions and haemofilter clots.
RESULTS: The study groups did not differ significantly in terms of age, sex and length of ICU stay. Haemofiltered patients had higher APACHE II scores (21 vs 15, p = 0.006), lower haemoglobin concentrations (102 vs 110 g/l, p = 0.0001) and higher blood transfusion rates (1.1 vs 0.3 units/day, p < 0.0001) when compared to the non-haemofiltered group. There was a positive correlation between haemofilter blood clot rate and blood transfusion rate (r = 0.48). More blood was transfused on days when haemofilter blood clots occurred than on days when no haemofilter clot occurred (1.0 vs 0.59 units, p = 0.03).
CONCLUSION: Haemofiltration is associated with an increased requirement for transfusion of blood. The temporal relationship between occurrence of haemofilter blood clots and transfusion of blood suggests that haemofilter lifespan may be an important determinant of this.

Entities:  

Mesh:

Year:  2000        PMID: 11193279     DOI: 10.1007/s001340000676

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  12 in total

Review 1.  Anticoagulation strategies in continuous renal replacement therapy: can the choice be evidence based?

Authors:  H M Oudemans-van Straaten; J P J Wester; A C J M de Pont; M R C Schetz
Journal:  Intensive Care Med       Date:  2006-02-02       Impact factor: 17.440

2.  Cooling and reduced risk of clotting within the extracorporeal continuous renal replacement circuit.

Authors:  Sean M Bagshaw; Andrew Davenport
Journal:  Intensive Care Med       Date:  2008-10-08       Impact factor: 17.440

3.  Building and validation of a prognostic model for predicting extracorporeal circuit clotting in patients with continuous renal replacement therapy.

Authors:  Xia Fu; Xinling Liang; Li Song; Huigen Huang; Jing Wang; Yuanhan Chen; Li Zhang; Zilin Quan; Wei Shi
Journal:  Int Urol Nephrol       Date:  2014-03-18       Impact factor: 2.370

4.  Simplified regional citrate anticoagulation using a calcium-containing replacement solution for continuous venovenous hemofiltration.

Authors:  Ling Zhang; Yujie Liao; Jin Xiang; Wei Qin; Xiaodong Wu; Yi Tang; Yingying Yang; Zhiwen Chen; Ping Fu
Journal:  J Artif Organs       Date:  2012-12-28       Impact factor: 1.731

5.  Evaluating the safety and efficacy of regional citrate compared to systemic heparin as anticoagulation for continuous renal replacement therapy in critically ill patients: A service evaluation following a change in practice.

Authors:  Roberta Borg; Debra Ugboma; Dawn-Marie Walker; Richard Partridge
Journal:  J Intensive Care Soc       Date:  2017-03-14

6.  Antithrombin level and circuit thrombosis during hemofiltration after cardiopulmonary bypass.

Authors:  H Lanquetot; T Leprince; S Ragot; C Boinot; C Jayle; R Robert; L Macchi
Journal:  Intensive Care Med       Date:  2008-06-25       Impact factor: 17.440

7.  Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: a prospective randomized study.

Authors:  Mehran Monchi; Denis Berghmans; Didier Ledoux; Jean-Luc Canivet; Bernard Dubois; Pierre Damas
Journal:  Intensive Care Med       Date:  2003-11-05       Impact factor: 17.440

8.  Anticoagulation, delivered dose and outcomes in CRRT: The program to improve care in acute renal disease (PICARD).

Authors:  Rolando Claure-Del Granado; Etienne Macedo; Sharon Soroko; YeonWon Kim; Glenn M Chertow; Jonathan Himmelfarb; T Alp Ikizler; Emil P Paganini; Ravindra L Mehta
Journal:  Hemodial Int       Date:  2014-03-12       Impact factor: 1.812

9.  Circuit life span in critically ill children on continuous renal replacement treatment: a prospective observational evaluation study.

Authors:  Jimena del Castillo; Jesús López-Herce; Elena Cidoncha; Javier Urbano; Santiago Mencía; Maria J Santiago; Jose M Bellón
Journal:  Crit Care       Date:  2008-07-25       Impact factor: 9.097

Review 10.  Clinical review: Patency of the circuit in continuous renal replacement therapy.

Authors:  Michael Joannidis; Heleen M Oudemans-van Straaten
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.